veterinari
medicin
account
substanti
portion
product
sale
consumpt
medicin
europ
probabl
worldwid
call
attent
fact
healthi
farm
anim
ensur
safe
suffici
livestock
product
meet
grow
demand
anim
protein
human
veterinari
medicin
share
mani
common
featur
express
symbolis
one
health
concept
concept
form
logic
basi
mainten
healthi
livestock
control
zoonos
foodborn
diseas
prevent
poor
sanitari
condit
reduct
microbi
parasit
threat
includ
resist
antibiot
antiparasit
drug
achiev
aim
requir
intern
cooper
interdisciplinari
action
new
initi
european
feder
pharmaceut
scienc
eufep
network
veterinari
medicinesha
potenti
manag
overcom
challeng
envis
network
system
pharmacolog
notabl
eufep
network
safeti
scienc
environ
pharmaceut
nanomedicin
well
regulatori
scienc
repres
promis
partner
new
technolog
introduc
veterinari
medicin
treatment
numer
frequent
speciesspecif
condit
scientif
input
differ
area
requir
evalu
potenti
benefitrisk
profil
novel
product
drug
deliveri
techniqu
medic
attent
anim
whole
drug
treatment
foodproduc
anim
inevit
affect
consum
safeti
public
health
administr
medicin
anim
may
result
presenc
drug
residu
edibl
tissu
product
milk
egg
honey
mani
question
surround
risk
human
health
environ
pose
exposur
veterinari
drug
residu
caus
great
concern
among
health
author
well
public
particular
share
use
mani
class
antimicrobi
veterinari
human
medicin
emerg
spread
resist
microb
anim
animalderiv
product
human
presenc
contamin
manur
environ
provok
deep
concern
throughout
world
network
veterinari
medicin
initi
see
broadli
posit
among
import
goal
contribut
legisl
issu
veterinari
medicin
develop
new
pharmaceut
anim
health
includ
novel
drug
deliveri
system
effort
support
academ
teach
train
veterinari
profession
formul
veterinari
drug
deliveri
also
consid
imper
object
network
pursuit
task
depend
interdisciplinari
cooper
among
expert
pharmaceut
veterinari
scienc
concentr
issu
scientist
academia
industri
regulatori
agenc
collabor
nation
intern
healthcar
bodi
well
organis
dedic
endors
teach
train
scientist
pharmaceut
veterinari
scienc
also
key
partner
major
object
network
includ
follow
strengthen
academ
research
promot
emerg
new
concept
principl
mechan
action
develop
innov
new
veterinari
medicin
product
support
educ
train
futur
healthcar
profession
veterinari
practic
pharmaci
industri
research
includ
continu
profession
develop
support
veterinari
univers
effort
network
encourag
european
commiss
initi
call
research
area
veterinari
medicin
horizon
call
place
format
strong
consortia
appli
fund
imi
eufund
project
success
network
depend
engag
expertis
cooper
specialist
benefit
experi
mean
eufep
network
veterinari
medicin
one
health
concept
veterinari
medicin
consider
part
total
product
use
medicin
worldwid
wide
recognit
concept
one
health
symbolis
mani
share
aspect
human
anim
health
zoonos
foodborn
diseas
poor
sanitari
condit
microbi
threat
resist
antibiot
antiparasit
drug
like
consequ
spread
environ
welldocu
major
challeng
share
medic
disciplin
one
health
concept
impress
substanti
fact
human
infecti
diseas
evolv
anim
pathogen
emerg
human
infecti
diseas
anim
diseas
origin
oie
valid
one
health
concept
also
support
mutual
use
mani
pharmaceut
substanc
least
ident
class
pharmaceut
veterinari
human
medicin
exampl
tabl
show
number
antimicrobi
substanc
use
anim
human
patient
among
share
antimicrobi
substanc
rd
th
gener
cephalosporin
fluoroquinolon
macrolid
classifi
critic
import
human
medicin
appear
also
import
treatment
varieti
anim
diseas
oie
latest
nobel
prize
medicin
award
scientist
develop
anim
antiparasit
drug
avermectin
seri
much
later
use
treat
crippl
parasit
diseas
among
major
human
popul
africa
primarili
elephantiasi
river
blind
campbel
food
deriv
healthi
anim
ensur
safe
suffici
livestock
product
help
combat
malnutrit
furthermor
worldwid
demand
anim
protein
estim
increas
fao
present
anim
diseas
expect
reduc
global
product
food
anim
vallat
intern
cooper
interdisciplinari
action
requir
sustain
healthi
livestock
safe
suffici
food
product
support
anim
human
health
safeguard
environ
safe
effect
pharmaceut
prudent
use
indispens
tool
approach
achiev
object
fao
new
initiativeth
eufep
network
veterinari
medicinesha
potenti
cope
challeng
instrument
invit
stimul
faculti
student
meaning
european
collabor
includ
creation
research
programm
applic
european
grant
contact
relev
european
regulatori
bodi
eg
ema
efsa
ecdc
other
well
sector
academia
industri
involv
research
develop
innov
medicin
deliveri
system
appear
crucial
network
activ
european
feder
pharmaceut
scienc
eufep
nonpartisan
organis
repres
nation
organis
individu
signific
interest
expertis
pharmaceut
scienc
regul
number
eufep
expertis
network
alreadi
establish
may
instrument
broaden
deepen
activ
network
veterinari
medicin
includ
network
system
pharmacolog
current
form
european
network
pharmacogenom
research
implement
eprin
well
network
bioavail
biopharmaceut
tabl
addit
eufep
network
safeti
scienc
environ
pharmaceut
nanomedicin
well
regulatori
scienc
promis
addit
partner
cooper
especi
true
mani
new
technolog
enter
area
veterinari
medicin
product
vmp
requir
signific
scientif
input
potenti
benefitrisk
profil
thoroughli
evalu
eufep
creat
year
ago
nation
pharmaceut
scienc
societi
faculti
member
make
pharmaceut
research
impact
fact
activ
driven
mostli
network
steer
committe
also
effici
cover
chang
regulatori
environ
especi
human
also
veterinari
pharmaceut
industri
eufep
resourc
manag
practic
support
activ
outlin
arrang
necessari
meet
confer
purpos
network
veterinari
medicin
primarili
help
fulfil
goal
eufep
rather
commit
address
impact
solut
ongo
issu
veterinari
medicin
scientist
involv
vmp
regulatori
assessor
pharmacologist
formul
scientist
work
veterinari
pharmaceut
industri
well
veterinari
clinic
expert
therefor
see
use
promot
principl
advanc
scienc
better
medicin
health
eu
worldwid
vmp
place
market
without
prior
author
market
vmp
regul
rule
establish
regul
ec
direct
amend
direct
procedur
obtain
market
authoris
vmp
similar
legisl
requir
human
medicin
product
addit
specif
requir
eg
refer
pharmaceut
formul
consum
safeti
environment
safeti
due
diverg
requir
manifold
option
treatment
differ
anim
speci
often
kept
distinct
livestock
farm
system
frequent
larg
number
vmp
need
produc
formul
sometim
uncommon
human
medicin
product
innov
administr
rout
vmp
often
paramount
limit
oral
use
eg
tablet
powder
intraven
inject
subcutan
well
intramuscular
inject
highli
common
vmp
special
administr
rout
requir
specif
pharmaceut
scienc
intramammari
formul
also
water
solubl
formul
applic
via
drink
water
transderm
spoton
formul
feed
medic
intrarumin
intrauterin
longact
formul
highpressur
percutan
formul
wide
use
effect
safe
administr
vmp
fact
veterinari
formul
may
sometim
precursor
use
human
requir
qualiti
vmp
human
medicin
product
essenti
similar
follow
rule
good
manufactur
practic
eufep
compet
pharmaceut
scienc
may
contribut
significantli
success
develop
new
innov
vmp
formul
provid
excel
platform
involv
issu
vmp
legisl
differ
product
intend
use
domest
anim
eg
dog
cat
use
treatment
food
produc
speci
rumin
pig
hors
poultri
fish
distinct
account
fact
administr
vmp
food
produc
anim
may
result
presenc
residu
foodstuff
obtain
anim
residu
activ
ingredi
excipi
degrad
product
form
storag
drug
metabolit
form
treat
anim
might
remain
anim
deriv
food
commod
compromis
health
consum
therefor
vmp
intend
treatment
food
produc
anim
may
contain
pharmacolog
activ
substanc
maximum
residu
limit
mrl
set
obligatori
establish
mrl
foodstuff
anim
origin
laid
regul
ec
substanc
safe
mrl
fix
insert
tabl
commiss
regul
eu
explicitli
forbidden
use
food
produc
anim
regulatori
author
work
procedur
extrapol
mrl
tissu
speci
possibl
obligatori
set
mrl
limit
legisl
direct
consequ
avail
vmp
minor
speci
eg
goat
dairi
sheep
rabbit
develop
specif
data
costli
justifi
invest
potenti
food
produc
hors
next
substanc
list
tabl
commiss
regul
eu
addit
therapeut
allow
accord
commiss
regul
eu
withdraw
period
six
month
expert
eufep
may
significantli
contribut
gener
evalu
data
food
safeti
relat
use
vmp
increas
consum
safeti
anim
welfar
accord
direct
amend
direct
ec
environment
risk
assess
mandatori
applic
market
author
veterinari
medicin
product
guidanc
document
ema
ema
ema
regul
assess
possibl
risk
environ
may
caus
use
product
phase
extent
environment
exposur
evalu
regard
target
speci
mass
use
vs
individu
treatment
administr
pattern
excretori
behaviour
etc
certain
threshold
valu
calcul
concentr
soil
predict
environment
concentr
pecsoil
water
environment
introduct
concentr
eicaquat
exceed
assess
complet
phase
trigger
paramet
violat
phase
ii
open
consid
physicochem
pharmacolog
toxicolog
characterist
product
includ
decomposit
behaviour
effect
certain
aquat
organ
eg
alga
aquat
invertebr
detail
potenti
ecotox
effect
veterinari
medicin
subject
combin
paramet
includ
amount
use
usag
pattern
rout
administr
metabol
degrad
storag
persist
soil
water
toxic
terrestri
aquat
organ
bioaccumul
potenti
boxal
et
al
broad
spectrum
endectocid
macrocycl
lacton
group
antimicrobi
belong
group
veterinari
medicin
product
present
caus
environment
concern
eufep
alreadi
establish
network
environ
pharmaceut
therefor
offer
expertis
field
environment
safeti
pharmaceut
substanc
metabolit
aquat
andor
terrestri
organ
tabl
addit
legisl
issu
develop
new
drug
substanc
deliveri
system
anim
health
avail
clinic
use
vmp
includ
immunolog
product
vaccin
initi
priorit
academ
teach
train
young
veterinari
profession
formul
veterinari
drug
deliveri
pursu
object
initi
would
benefit
collabor
alreadi
exist
eufep
network
addit
cooper
academia
industri
government
regulatori
institut
nation
intern
healthcar
bodi
organis
dedic
teach
train
young
scientist
pharmaceut
veterinari
scienc
also
potenti
key
partner
object
could
achiev
increas
interact
expert
pharmaceut
veterinari
scienc
thu
identifi
issu
scientist
academia
industri
regulatori
agenc
work
togeth
promot
interdisciplinari
exchang
experi
knowledg
among
human
medic
veterinari
medic
pharmaceut
disciplin
use
network
form
research
consortia
strengthen
academ
research
promot
emerg
new
concept
principl
mechan
action
develop
innov
new
vmp
medicin
product
support
develop
academ
research
field
veterinari
pharmaceut
scienc
regard
vmp
develop
pharmacolog
toxicolog
innov
deliveri
system
veterinari
univers
perhap
small
develop
research
phd
programm
support
educ
train
futur
healthcar
profession
veterinari
practic
pharmaci
industri
research
includ
continu
profession
develop
initi
promot
research
pharmaceut
scienc
concentr
effort
replenish
arsen
medicin
intend
use
anim
address
shortag
avail
therapeut
minor
use
andor
minor
speci
encourag
european
commiss
initi
call
research
area
veterinari
medicin
horizon
call
place
form
strong
consortia
appli
fund
imi
eufund
scope
network
veterinari
medicin
initi
link
extens
rang
veterinari
pharmaceut
scienc
includ
vast
rang
respons
veterinari
pharmaci
profess
research
educ
student
public
health
industri
academia
government
institut
also
practic
core
compet
envisag
network
address
issu
relat
avail
safe
vmp
potenti
superior
efficaci
focu
also
possibl
concurr
intend
use
human
medicin
central
field
interest
safeti
vmp
includ
protect
user
eg
veterinari
surgeon
farmer
drug
toler
target
anim
environment
toler
addit
fate
variou
ingredi
vmp
includ
metabolit
form
anim
excret
via
urin
faec
persist
biolog
activ
environ
attract
major
scientif
interest
instanc
presenc
human
well
veterinari
antibiot
soil
water
potenti
role
promot
resist
bacteria
becom
matter
great
interest
xi
et
al
use
steroid
steroidlik
agent
substanc
promot
growth
anim
hormonelik
action
strictli
prohibit
european
union
eu
council
direct
amend
direct
state
residu
certain
substanc
thyrostat
oestrogen
androgen
gestagen
activ
may
danger
consum
may
also
affect
qualiti
foodstuff
anim
origin
tradit
growthpromot
substanc
probabl
still
develop
misus
recent
genet
technolog
ie
gene
dope
appear
horizon
becom
realist
although
illeg
perform
enhanc
option
gene
dope
approach
may
constitut
attract
option
anim
husbandri
food
product
ii
anim
perform
particularli
regard
sport
control
illeg
use
growth
promot
substanc
manipul
gene
requir
adequ
knowledg
veterinari
drug
legisl
anim
protect
law
well
intern
standard
guidelin
rule
appli
sport
anim
control
exercis
cooper
support
offici
bodi
regul
control
market
use
vmp
andor
intern
antidop
organis
scientif
advanc
technolog
includ
analysi
metabolom
proteom
drug
residu
monitor
screen
techniqu
also
necessari
addit
silicomathemat
modelbas
approach
might
complet
spectrum
investig
method
requir
address
dope
mochel
et
al
object
best
achiev
help
capabl
specialis
network
explicitli
dedic
solv
problem
relat
veterinari
medicin
number
veterinari
drug
therapi
problem
current
await
solut
mention
strongli
link
human
medicin
due
varieti
anim
speci
indic
taken
consider
rang
issu
relat
use
veterinari
medicin
broad
heterogen
among
urgent
problem
global
emerg
spread
antibiot
resist
carri
potenti
futur
ineffect
antimicrobi
treatment
veterinari
human
medicin
phenomenon
coand
crossresist
abil
transfer
resist
one
speci
bacteria
anoth
eg
horizont
resist
transfer
commens
bacteria
human
pathogen
make
situat
even
problemat
promin
exampl
methicillinresist
staphylococcu
aureu
infect
whether
hospit
commun
livestockacquir
worth
mention
accord
recent
report
sale
data
antimicrobi
agent
eueea
countri
antimicrobi
substanc
use
food
produc
anim
amount
ton
clearli
exceed
total
use
human
amount
ton
ecdc
european
centr
diseas
prevent
control
et
al
novel
antibiot
use
veterinari
medicin
avail
near
futur
new
pharmacolog
approach
combat
bacteri
infect
must
therefor
consid
appli
prophylact
metaphylact
therapeut
manag
bacteri
viral
infect
individu
anim
whole
flock
also
vmp
indic
mention
call
minor
use
minor
anim
speci
sheep
goat
fish
farm
deer
even
honey
bee
ema
due
small
size
market
spectrum
avail
pharmaceut
limit
accompani
adequ
commerci
return
invest
addit
problem
antibiot
resist
resist
anthelmint
drug
emerg
excess
irrat
use
anthelmint
drug
result
resist
nematod
today
report
resist
drug
class
avail
market
ie
benzimidazol
tetrahydropyrimidin
macrocycl
lacton
kaplan
vidyashankarb
mani
part
world
even
multipleresist
parasit
preval
cezar
et
al
sinc
introduct
ivermectin
one
macrocycl
lacton
novel
anthelmint
drug
class
develop
use
livestock
hors
except
monepantel
new
zealand
emerg
anthelmint
resist
problem
anim
human
health
addit
knowledg
pharmacolog
featur
anthelmint
requir
optim
pharmacolog
activ
achiev
sustain
use
howev
also
pharmacotherapeut
gap
relat
treatment
major
food
anim
speci
cattl
sheep
pig
chicken
salmon
reason
consum
protect
number
pharmacolog
substanc
withdrawn
market
without
replac
new
author
compound
compel
exampl
recent
ban
nitroimidazol
nitrofuran
left
therapeut
option
treatment
protozoan
infect
turkey
histomona
meleagridi
caus
blackhead
diseas
cow
infect
trichomona
foetu
show
clinic
sign
infertil
gener
expertis
concern
pharmacokinet
pharmacodynam
properti
avail
therapeut
substanc
embed
clinic
context
appli
contribut
anim
welfar
efficaci
vmp
use
practic
public
health
food
safeti
recent
develop
area
help
optimis
select
formul
vmp
specif
case
well
appli
dosag
regimen
addit
unansw
question
relat
drug
treatment
veterinari
medicin
exampl
lack
deficit
advanc
techniqu
model
simul
drug
disposit
kinet
differ
anim
speci
continu
lack
altern
classic
antibiot
altern
substancesprophylact
approach
view
increas
microbi
resist
problem
relat
problem
certain
antiparasit
eg
anthelmint
resist
mani
unresolv
pharmacotherapeut
issu
veterinari
medicin
number
heterogen
characterist
exceed
scope
paper
includ
lack
eye
medic
cytostat
agent
dog
cat
antiparasit
eg
tick
cat
vaccin
immunolog
product
eg
emerg
diseas
middl
east
respiratori
syndrom
regulatori
scientif
challeng
relat
novel
method
treatment
stem
cell
therapi
antivir
therapi
individu
treatment
option
regulatori
issu
among
core
compet
eufep
network
essenti
element
complex
legal
framework
govern
medicin
product
european
union
present
revis
among
instanc
regul
ec
set
commun
procedur
authoris
supervis
medicin
product
human
veterinari
use
addit
work
current
progress
draft
novel
regul
european
parliament
council
veterinari
medicin
product
european
commiss
object
revis
current
legisl
vmp
follow
increas
avail
vmp
reduc
administr
burden
stimul
competit
innov
improv
function
intern
market
address
veterinari
public
health
issu
relat
antimicrobi
resist
addit
area
interest
network
veterinari
medicin
may
includ
drug
categori
without
legal
commun
prescript
eg
relat
product
use
autogen
herdspecif
vaccin
medic
product
veterinari
use
recent
studi
reveal
extrem
heterogen
among
nation
legisl
herdspecif
vaccin
european
countri
despit
import
class
vaccin
intern
harmonis
terminolog
well
intern
product
standard
current
miss
attia
et
al
addit
issu
relat
gener
vmp
discuss
past
although
market
product
expect
increas
competit
lead
price
cut
enhanc
avail
argu
characterist
gener
may
differ
origin
product
eg
respect
pharmaceut
equival
clinic
efficaci
junquera
toutain
bousquetmel
identif
foster
appropri
teach
techniqu
essenti
rais
awar
increas
interest
pharmacolog
toxicolog
safeti
scienc
public
health
issu
relat
use
vmp
prudent
use
antibiot
antiparasit
veterinari
commun
also
includ
new
develop
current
regul
nation
commun
level
improv
relat
practic
veterinari
medicin
interact
among
scientist
lectur
work
academia
relat
institut
support
understand
requir
vmp
includ
optim
use
ii
potenti
benefit
pharmaceut
feasibl
achiev
develop
innov
product
veterinari
medicin
manag
veterinari
pharmaci
storag
transport
drug
veterinari
vehicl
import
pharmacovigil
environment
safeti
student
profession
veterinari
medicin
offer
thorough
pharmacolog
train
classic
pharmacolog
rare
includ
standard
univers
curriculum
topic
signific
includ
numer
area
pharmacolog
may
tabl
class
antibiot
use
veterinari
human
medicin
class
allow
treatment
foodproduc
speci
list
applic
antimicrobi
substanc
princip
associ
risk
induc
antibiot
resist
anim
human
rang
strategi
develop
promis
pharmacolog
candid
market
distribut
medicin
product
addit
collabor
pharmaceut
scientist
eg
underlin
import
formul
promot
veterinari
student
well
student
pharmaci
made
awar
job
opportun
institut
involv
preclin
safeti
evalu
drug
intend
use
veterinari
human
medicin
due
uniqu
train
combin
knowledg
skill
anim
scienc
well
pharmacolog
toxicolog
veterinari
graduat
ideal
candid
posit
avail
pharmaceut
industri
within
regulatori
bodi
field
relat
assess
safeti
andor
efficaci
new
investig
drug
develop
innov
medicin
meet
unmet
need
veterinari
medicin
particip
revis
current
regulatori
framework
advanc
train
scientist
work
research
develop
vmp
fall
scope
eufep
network
veterinari
medicin
initi
success
initi
depend
engag
expertis
cooper
specialist
like
benefit
experi
mean
eufep
network
council
direct
april
concern
prohibit
use
stockfarm
certain
substanc
hormon
thyrostat
action
biopharmaceut
form
bedrock
mani
activ
societi
contribut
eufep
member
societi
activ
network
provid
import
opportun
assist
legislatur
defin
harmonis
approach
across
europ
eg
bioavail
bioequival
guidelin
effort
focu
scientif
question
aris
poorli
understood
area
network
provid
platform
focus
research
best
appli
find
learn
practic
includ
collabor
contribut
personalis
medicin
precis
medicinebi
promot
pharmacogeneticgenom
knowledg
expertis
establish
clinic
evid
safe
effect
medicin
treatment
use
medic
base
patient
genet
predisposit
network
address
scientif
achiev
discuss
variou
issu
relat
pharmaceut
exposur
environ
includ
attempt
toward
global
harmonis
network
focus
pharmaceut
biomed
scienc
diagnost
therapeut
aspect
nanomedicin
primarili
cooper
relat
nanotechnolog
field
network
power
sciencebas
process
understand
qualitybydesign
medicin
also
contribut
educ
train
field
foster
handson
implement
system
approach
emerg
technolog
pharmaceut
product
process
network
offer
academ
industri
regulatori
profession
variou
scientif
field
brainstorm
meet
workshop
discuss
strateg
goal
key
issu
translat
research
cover
pharmaceut
scienc
network
dedic
develop
safeti
scienc
medicin
organis
sever
workshop
focus
educ
train
safeti
scientist
european
innov
medicin
initi
imi
educ
train
project
safeti
scienc
stem
network
still
ongo
common
aim
promot
scientif
collabor
cooper
coordin
support
joint
activ
engag
educ
train
thu
forum
academ
industri
regulatori
profession
respect
scientif
field
develop
system
pharmacolog
emerg
new
network
one
propos
articl
veterinari
medicin
